Takeda Pharmaceutical TAK
NYSE TAK
$17.86 -0.01 (-0.06%)
At close: Oct 2, 2026 · 4:00 PM EDT

Takeda Pharmaceutical (TAK) Other Non Operating Income (2019)

Updated

Takeda Pharmaceutical's Other Non Operating Income was $70.62 million in the quarter ended Mar 31, 2019.

Analysis

Takeda Pharmaceutical (TAK) Other Non Operating Income (2019) Analysis & Trends

  • In earlier years, Other Non Operating Income was -$23.2 million in the year ended Dec 31, 2018, $7.4 million in the year ended Dec 31, 2017 and -$25.6 million in the year ended Dec 31, 2016.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Takeda Pharmaceutical 2.58 Bn -23.92 Bn 5.10 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2019 70.62 Mn
API Access

Takeda Pharmaceutical Other Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-operating-income&ticker=TAK&period=max&api_key=YOUR_API_KEY